Stay updated on ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.

Latest updates to the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ZW49 clinical trial record is displayed with its study design, eligibility criteria, outcomes, locations, and completion status.SummaryDifference60%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check52 days agoChange DetectedRemoval of the 403 Forbidden error page content (HTML doctype, '403 Forbidden' message, and the Home link) from the page. This indicates the page no longer displays an error state and can render the normal study details view.SummaryDifference0.5%

Stay in the know with updates to ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.